Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Archiv Der Pharmazie
|
June 15, 1999
Interaction of Viagra with the NO donors molsidomine and RE 2047 with regard to antithrombotic and blood pressure lowering activities
K Rehse, H Scheffler, N Reitner
Journal of Clinical Microbiology
|
July 1, 1994
Evaluation of rapid commercial enzyme immunoassay for detection of Giardia lamblia in formalin-preserved stool specimens
E H Scheffler, L L Van Etta
Archiv Der Pharmazie
|
November 1, 1996
New NO-donors with antithrombotic and vasodilating activities, Part 14. 1,3,4-Triazol-1-oles
K Rehse, D Piechocki, M Schober, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
September 19, 2024
SGLT2 inhibitors and kidney outcomes across the spectrum of kidney disease: a systematic review and meta-analysis
Bernardo F Spiazzi, Giovana F Piccoli, Laura F Wayerbacher, et al.
Diabetes Research and Clinical Practice
|
November 20, 2024
SGLT2 inhibitors, cardiovascular outcomes, and mortality across the spectrum of kidney disease: A systematic review and meta-analysis
Bernardo F Spiazzi, Giovana F Piccoli, Laura F Wayerbacher, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Archiv Der Pharmazie
|
June 15, 1999
Interaction of Viagra with the NO donors molsidomine and RE 2047 with regard to antithrombotic and blood pressure lowering activities
K Rehse, H Scheffler, N Reitner
Journal of Clinical Microbiology
|
July 1, 1994
Evaluation of rapid commercial enzyme immunoassay for detection of Giardia lamblia in formalin-preserved stool specimens
E H Scheffler, L L Van Etta
Archiv Der Pharmazie
|
November 1, 1996
New NO-donors with antithrombotic and vasodilating activities, Part 14. 1,3,4-Triazol-1-oles
K Rehse, D Piechocki, M Schober, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
September 19, 2024
SGLT2 inhibitors and kidney outcomes across the spectrum of kidney disease: a systematic review and meta-analysis
Bernardo F Spiazzi, Giovana F Piccoli, Laura F Wayerbacher, et al.
Diabetes Research and Clinical Practice
|
November 20, 2024
SGLT2 inhibitors, cardiovascular outcomes, and mortality across the spectrum of kidney disease: A systematic review and meta-analysis
Bernardo F Spiazzi, Giovana F Piccoli, Laura F Wayerbacher, et al.
Page
of 1